Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LINACLOTIDE
- Clinical Study of Bowel Preparation Before Colonoscopy
- A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) With Functional Constipation Who Are Treated With Linaclotide
- A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional Constipation
- Application of Linaclotide Capsule in Bowel Preparation for Patients at High Risk of Inadequate Bowel Preparation
- Application of Linaclotide Capsule in Bowel Preparation for Colonoscopy
- Effect and Safety of Polyethylene Glycol Combined With Linaclotide on Colon Cleansing for Patients With Chronic Constipation
- Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders
- GCC Agonist Signal in the Small Intestine
- Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic Constipation
- Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C
- Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation
- Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)
- Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer
- A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
- Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation
- A Study of the Effect of Linaclotide on Abdominal Girth in Participants With IBS-C
- A Study of Oral Dosing of ASP0456 in Patients With Chronic Constipation
- An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
- A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
- A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
- Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
- Single-dose Linaclotide for Capsule Endoscopy Preparation
- A Study to Evaluate Dose Responses of Efficacy and Safety of ASP0456 in Patient With Chronic Constipation
- Caecal pH as a Biomarker for Irritable Bowel Syndrome
- Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome
- Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
- Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
- Efficacy of Linaclotide to Senna for CIC
- A Lactation Study in Women Who Are Breastfeeding or Pumping and Are Receiving Linaclotide Therapeutically
- Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients
- Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers
- A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
- A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome
- Safety and Efficacy of Linaclotide in Patients With Chronic Constipation and Prominent Abdominal Bloating
- A Study to Evaluate Safety of Multiple Dose of ASP0456 in Healthy Subjects
- A Safety and Pharmacokinetics Study of ASP0456 in Healthy Subjects
- Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation
- Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
- Phase III, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
- Trial of Linaclotide in Patients With Chronic Constipation
- Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
- Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation
Clinical trials list
click for details